Predictors of recurrence after radiotherapy for non-melanoma skin cancer

Current Oncology

Volumn 21, Issue 2, 2014, Pages

  Khan, L ^a   Breen, D ^a   Zhang, L ^a   Balogh, J ^a   Czarnota, G ^a   Lee, J ^a   Tsao, M N ^a   Barnes, Elizabeth A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Radiotherapy; Recurrence; Skin cancer

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; RADIATION DOSE; RISK; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; TOXICITY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 84898772277     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.1727     Document Type: Article

References (15)

1. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7.
2. Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 2004;60:406-11.
3. Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004;329:705.
4. Childers BJ, Goldwyn RM, Ramos D, Chaffey J, Harris JR. Long-term results of irradiation for basal cell carcinoma of the skin of the nose. Plast Reconstr Surg 1994;93:1169-73.
5. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-90.
6. Locke J, Karimpour S, Young G, Lockett MA, Perez CA. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 2001;51:748-55.
7. Tsao MN, Tsang RW, Liu FF, Panzarella T, Rotstein L. Radiotherapy management for squamous cell carcinoma of the nasal skin: the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 2002;52:973-9.
8. Silva JJ, Tsang RW, Panzarella T, Levin W, Wells W. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 2000;47:451-9.
9. van Hezewijk M, Creutzberg CL, Putter H, et al. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiother Oncol 2010;95:245-9.
10. Brantsch KD, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008;9:713-20.
11. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005;353:2262-9.
12. Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 1989;11:222-32.
13. Griep C, Davelaar J, Scholten AN, Chin A, Leer JW. Electron beam therapy is not inferior to superficial X-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1347-50.
14. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 1: overview. J Dermatol Surg Oncol 1991;17:713-18.
15. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.